Rights and permissions
About this article
Cite this article
Gemcitabine improves the outlook for NSCLC patients. Pharmacoecon. Outcomes News 280, 10 (2000). https://doi.org/10.1007/BF03267405
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03267405